What is the prevalence of Coffin-Lowry syndrome?

TL;DR: Coffin-Lowry syndrome is a rare genetic disorder with an estimated prevalence ranging from 1 in 50,000 to 1 in 100,000 individuals worldwide. Because the condition is frequently underdiagnosed or misdiagnosed due to its variable clinical presentation, these figures are considered estimates rather than exact counts.

What is the estimated prevalence and incidence of Coffin-Lowry syndrome?

Determining the exact prevalence of Coffin-Lowry syndrome is challenging because the disorder is rare and often goes unrecognized in mild cases. Current medical literature, including data from Orphanet and the NIH Genetic and Rare Diseases (GARD) Information Center, estimates the prevalence to be between 1 in 50,000 and 1 in 100,000. Because Coffin-Lowry syndrome is a genetic condition, the incidence remains relatively stable, though precise annual birth rates are difficult to calculate due to the lack of a universal registry. Within the DiseaseMaps.org community, 84 people with Coffin-Lowry syndrome have connected, providing a vital real-world perspective that helps researchers understand the lived experience beyond clinical statistics.

Does Coffin-Lowry syndrome affect males and females differently?

Coffin-Lowry syndrome is inherited in an X-linked dominant pattern. Because of this, the clinical manifestation and severity often differ between genders:

• Males: Typically exhibit more severe physical and cognitive symptoms because they have only one X chromosome.


• Females: Often present with a milder or more variable phenotype due to X-inactivation, though they can still be significantly affected by the condition.

Are there geographic or ethnic variations in the prevalence of Coffin-Lowry syndrome?

There is no evidence to suggest that Coffin-Lowry syndrome is more prevalent in any specific geographic region or ethnic group. The condition occurs globally and appears to affect populations with equal frequency. The primary challenge in identifying the true global prevalence remains the lack of widespread genetic screening and the potential for Coffin-Lowry syndrome to be misdiagnosed as other conditions involving intellectual disability or distinctive facial features.

Why is accurate data on Coffin-Lowry syndrome difficult to obtain?

The rarity of Coffin-Lowry syndrome, combined with its phenotypic variability, contributes to significant underdiagnosis. Many individuals with milder forms may never receive a formal genetic diagnosis, or they may be diagnosed later in life. Furthermore, because Coffin-Lowry syndrome involves a mutation in the RPS6KA3 gene, clinicians may not always suspect the syndrome during routine evaluations for developmental delays. Real-world data, such as that gathered by the 84 members of our community, remains essential for filling the gaps left by traditional epidemiological studies.

Next steps

• Consult with a clinical geneticist to discuss molecular genetic testing for the RPS6KA3 gene.


• Connect with the DiseaseMaps.org community to share experiences and learn from others living with Coffin-Lowry syndrome.


• Maintain regular follow-ups with a multidisciplinary team, including neurologists and physical therapists, to manage specific symptoms.


• Monitor the NIH GARD website for updates on ongoing clinical research and potential therapeutic trials.

Medical disclaimer: This content is for informational purposes only and does not constitute professional medical advice, diagnosis, or treatment; always seek the advice of your physician or other qualified health provider with any questions regarding a medical condition.

References

• Orphanet: Coffin-Lowry syndrome (ORPHA:197).


• NIH Genetic and Rare Diseases (GARD) Information Center: Coffin-Lowry syndrome.


• OMIM (Online Mendelian Inheritance in Man): Coffin-Lowry Syndrome; CLS (Entry #303600).


• DiseaseMaps.org: Community insights and patient-led data for rare disease awareness.